SSII
Ss Innovations International
NASDAQ · Health Care
$3.79
+0.39 (+11.47%)
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 7.86M | 294.54M | 262.27M | 240.92M |
| Net Income | -27,900,809 | 41.36M | 39.46M | 27.71M |
| EPS | — | — | — | — |
| Profit Margin | -355.1% | 14.0% | 15.1% | 11.5% |
| Rev Growth | — | +7.6% | +2.3% | +6.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 91.27M | 118.45M | 152.33M | 135.17M |
| Total Equity | 275.65M | 508.27M | 516.61M | 488.41M |
| D/E Ratio | 0.33 | 0.23 | 0.29 | 0.28 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -26,893,979 | 48.96M | 47.08M | 43.40M |
| Free Cash Flow | — | 24.60M | 19.43M | 18.07M |